Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 4Phase NA 2Phase EARLY_PHASE1 1

Status

Completed 9Recruiting 4Unknown 3Terminated 3Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 3FED 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other solid neoplasm 1Other 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Radiation-induced Oral Mucositis 1Prostate Cancer Recurrent 1Melanoma 1Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 109Cyclophosphamide 89fludarabine 70Carboplatin 57Injections 56Bevacizumab 49Specimen Handling 43Gemcitabine 41Magnetic Resonance Spectroscopy 40Paclitaxel 39Nivolumab 38venetoclax 36Dexamethasone 35Cisplatin 34Biopsy 34Temozolomide 31Docetaxel 29atezolizumab 27Capecitabine 27Oxaliplatin 26Fluorouracil 26Pemetrexed 24Irinotecan 24Azacitidine 24abemaciclib 23toripalimab 22Fulvestrant 22fludarabine phosphate 21Rituximab 21Leucovorin 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Recruiting × Hydroxychloroquine × Clear all
NCT05036226 2026-05-13

COAST

Medical University of South Carolina

Phase 1/2 Recruiting
76 enrolled
GenitourinaryOther solid neoplasm

Prostate Cancer Recurrent

NCT04464759 2026-05-11

LIMIT

Abramson Cancer Center at Penn Medicine

Phase 1/2 Recruiting
94 enrolled
Dermatologic

Melanoma

NCT05842174 2026-04-16

TAQE

VA Office of Research and Development

Phase 1/2 Recruiting
93 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT06939582 2025-04-29

RIOM

West China Hospital

Phase 1/2 Recruiting
158 enrolled
Other

Radiation-induced Oral Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡